RFA-MH-27-180: Advancing Research on Empirically-Supported Interventions for Older Adults Living with Serious Mental Illness (R01 Clinical Trial Optional)

RFA-MH-27-180: Advancing Research on Empirically-Supported Interventions for Older Adults Living with Serious Mental Illness (R01 Clinical Trial Optional)

Key details table

This opportunity is one of the stronger policy-aligned mental health grants in the 2026 pipeline because it sits at the interface between implementation science, service systems research, and geriatric mental health outcomes. Unlike classic mechanistic studies that focus only on neurobiology, this NOFO explicitly rewards research that can improve how evidence-based interventions perform in real-world care settings.

Why this is a 2026/2027-relevant opportunity

RFA-MH-27-180 was posted in late May 2026, with an open date in September and a due date in October. It is therefore directly relevant to the upcoming 2026 application cycle while also projecting into FY2027 funding timing.

A practical way to evaluate relevance is to map it to your own planning:

• If your team is already preparing a proposal in late 2026, this is immediate because the opportunity is currently in active cycle with a near-term deadline.
• If you are planning FY2027 submission strategy, this call is also relevant because the announcement clearly states a FY 2027 award target and a defined expected start timeline.
• If your project is focused on older adults with SMI, service workflows, implementation, or care-system redesign, this NOFO is purpose-built.

Although it is a single NOFO, it is not a narrow niche-only grant. It is broad in mechanism (interventions can be person-level, system-level, or hybrid approaches), but strict in focus (must address older adults with SMI and practical deployment).

What this funding supports, in plain terms

The NOFO calls for research that adapts and tests empirically-supported or evidence-based interventions for adults 50 years and older with serious mental illness, including schizophrenia-spectrum disorders, bipolar disorder, major depression, PTSD, OCD, and related severe disorders. The funding is intended for approaches that can improve real-world outcomes in settings where older adults actually receive care.

The key interpretation to make is this:

• This is not just clinical efficacy research in a lab environment.
• This is not purely “prove it works in a controlled experiment” science.
• It emphasizes what works in routine practice: access, continuity, quality, safety, sustainability, workforce feasibility, and uptake.

The announcement explicitly defines older adult as age 50+ with SMI and emphasizes deployment-focused, implementation-aware research. In review terms, interventions are judged not only by statistical outcomes but also by whether they can be delivered in ordinary clinics, long-term care settings, assisted living, ED-based pathways, or community settings with limited friction.

This means a successful proposal is often a design that brings together:

1. An empirically-supported intervention (or system-level strategy)
2. A deployment model that respects existing workflows
3. A clear strategy to assess mechanism and implementation
4. Evidence that it can be sustained and scaled in real systems

Who should consider applying

This is for investigators and teams who already work on a practical edge of mental health research:

• Clinical researchers translating interventions into care models
• Systems scientists testing implementation strategies for service delivery
• Teams combining behavioral health intervention content with service system redesign
• Academic + practice-community partnerships willing to build co-designed studies
• Groups with access to administrative or electronic health systems to evaluate outcomes at scale

An important practical signal in the solicitation is the explicit encouragement of partnerships. It expects collaboration with practice settings and community systems, not isolated experiments. If your proposal has no clear pathway into routine care settings (for example only a tightly controlled efficacy protocol without deployment planning), it is likely to be judged non-responsive.

The opportunity also permits both clinical-trial optional and non-clinical-trial designs. It is suitable for intervention development and optimization, service process research, and implementation designs such as hybrid trials.

Eligibility rules and constraints that matter most

The eligibility section is unusually broad on applicant organization types, but the NOFO adds strict operational constraints. This combination is important:

• Eligible organizations are broad: universities, nonprofits, for-profit organizations (including small businesses), local/state entities, federal agencies, and more.
• Foreign subawards/subcontracts are constrained by NIH’s international collaboration policy and now treated as noncompliant for this NOFO.
• Non-domestic entities can apply in the right form, but teams should verify current compliance before submission.
• Cost sharing is not required.

The most important operational rule is registrations:

1. SAM registration must be active
2. eRA Commons registration in place (including PI registration)
3. Grants.gov registration active
4. ORCID linked to PD/PI account

For teams that are late to this cycle, these are not optional. The notice explicitly states registration is a hard precondition and not a valid excuse for late submission.

What makes a proposal non-responsive

The NOFO is explicit about nonresponsive applications. Use this as a compliance checklist:

• The project must be focused on interventions/services for older adults 50+ with SMI.
• Psychopathology-only studies without intervention/service testing are not sufficient.
• Studies that require research-therapy settings without transfer to routine care can fail as nonresponsive.
• Person-level interventions often need hybrid effectiveness-implementation design.
• If testing mechanisms or implementation pathways without rigorous design fit to outcomes, review risk increases.
• Multisite trials are allowed, but you must demonstrate practical execution, analytic plan, and partnership strength.

If your study protocol reads like pure clinical explanatory research and not implementation-oriented optimization, this is usually a misfit.

Application process and timeline

From a planning perspective, this NOFO’s process is straightforward but strict.

Key schedule logic

• September 15, 2026: earliest submission date
• October 15, 2026: due date
• October 16, 2026: expiration date
• FY 2027 expected start: July 2027 (per review and award flow in the NOFO)

Even with only one due date visible in the main call, applicants should still treat this as a “full lifecycle” process:

1. Build internal team and compliance readiness first
2. Draft proposal and build required registrations
3. Internal pre-submission checks
4. Submit via one of three systems (ASSIST, system-to-system, Grants.gov Workspace)
5. Track eRA Commons before deadline
6. Correct resubmission issues before due time if compliance flags appear

Submission route

Applications can be submitted via:

• NIH ASSIST
• institutional system-to-system (S2S)
• Grants.gov Workspace

The NOFO stresses that paper is not accepted. Full compliance with NIH application package instructions is strictly enforced.

Practical timeline to avoid avoidable failure

If your due date is October 15, this is the right sequencing:

• 8 weeks prior: finalize intervention scope, confirm partnership model, and lock endpoints.
• 6 weeks prior: prepare budgets and staffing plans with budget justification.
• 4 weeks prior: build draft in submission system and run internal pre-checks.
• 2 weeks prior: review CDE/data sharing and human-subject sections.
• 5 days prior: test submission portal and correct all warnings.
• 1 day prior: review full application in eRA Commons.
• Same day: final submission and confirmation.

This is not over-cautious process management. For NIH, late corrections after deadline are common fatal points.

Budget and award structure: what the numbers imply

The NOFO does not fix one grant size, but it does define the pool and award count:

• $3,000,000 FY 2027 budget intent
• 5 to 6 anticipated awards
• Up to 5 years project period

Since budgets are not formally capped, teams should submit realistic, evidence-grounded budgets.

This does not mean “budget can be anything.” It means:

• justify costs in terms of planned sample, sites, fidelity monitoring, and implementation steps
• include CDE/data and implementation monitoring requirements where relevant
• align staffing and infrastructure costs with deployment design

A common trap is proposing a high-cost model without explicit maintenance and rollout plans. This NOFO is aimed at operationally scalable work, so reviewer committees often see through under-justified resource inflation.

Review criteria and how to maximize fit

NIH review uses the standard scientific merit framework, with application-specific weighting:

• significance and innovation
• approach and rigor
• feasibility
• investigator expertise and environment
• specific NOFO criteria on deployment and implementation

The review language in this solicitation repeatedly returns to three themes:

1. Can this improve real-world care in community-relevant settings?
2. Can it address mechanism and implementation together (especially for person-level interventions)?
3. Are the partnerships and data plans credible at site and system level?

What reviewers typically prioritize

• Clear target population alignment (older adults with SMI)
• Direct pathway from intervention to measurable real-world outcomes
• Appropriate analytic design for deployment settings
• Explicit plans to assess mechanism, uptake, and outcomes
• Inclusion strategy and representativeness
• Feasible sample and site recruitment strategy

In this call, “good science” and “usable service design” are inseparable. A proposal can fail either way if it is too exploratory and lacks execution depth, or too methodological and disconnected from care systems.

Why this may be strategically better than a standard R01

For teams used to NIH R01 norms, this NOFO is still an R01 but with explicit intervention utility expectations. That changes strategy:

• Compared with classic efficacy R01s: stronger emphasis on practical implementation and system integration.
• Compared with implementation-only calls: still requires strong clinical or service-intervention substance.
• Compared with grants for early-stage discovery: this is not a basic science call; it is an applied translational step where outcomes matter in realistic settings.

In practice, that means this NOFO works best for teams who can provide:

• an intervention with prior evidence base,
• a clear adaptation path,
• a realistic service redesign plan,
• and measurement of uptake, fidelity, access, and continuity outcomes.

Common mistakes and hard-won lessons

1) Proposing a lab-only intervention

The NOFO repeatedly rejects research focused exclusively on pathology without service delivery adaptation. If the project sits only in controlled settings, it does not meet intent.

2) Ignoring deployment-focused requirements

You should not assume a classic efficacy design is sufficient. The announcement asks for deployment-focused work, including feasibility in routine care contexts.

3) Weak partnership architecture

Many teams build strong science but weak implementation logic. If collaboration with clinics, community services, or care systems is cosmetic, proposals lose competitive edge and often fail non-responsive checks.

4) Missing eRA Commons and submission system rigor

Registration gaps are a common silent killer. The most painful failures are not scientific but administrative: missing Commons/ORCID links, incomplete registration, or late portal errors.

5) Underestimating data requirements

The NOFO encourages common data elements and often expects careful plans for CDE data architecture in human subject research. If data systems are not planned for collection and reporting, review questions arise quickly.

6) Unclear distinction between innovation and adaptation

A lot of applicants submit “nice idea” studies that do not show why adaptation of existing evidence is needed for older adults with SMI. Show the gap: what is missing in current care and why your approach improves accessibility, implementation, or outcomes.

Practical readiness checklist

If you are preparing an application, complete this checklist before drafting narrative:

• Confirm your team has legal/compliance registrations (SAM, eRA Commons, Grants.gov).
• Define your primary intervention system: person-level trial, system-level strategy, or mixed design.
• Ensure your sample definition uses the NOFO’s target population definition (adults 50+ with SMI).
• Verify your design contains either hybrid effectiveness-implementation or equivalent deployment-focused logic.
• Build outcome set that includes access, engagement, quality, continuity, and sustainability signals.
• Map all required sections in SF424(R&R), especially research strategy and human subject components.
• Add explicit risk/milestone handling and site recruitment feasibility plan.
• Identify at least one practice/community partner for implementation realism.
• Build a timeline for internal compliance review before the October 15 due date.

These are not extras. They are exactly the mechanics that separate responsive from nonresponsive applications.

FAQ for planning quickly

Is this call limited to a single institution type?

No. The NOFO is broad in eligible organization types but strong in topical scope. The hard restriction is focus on older adults with SMI and practical intervention systems, not institutional narrowness.

Is funding per award specified?

No fixed per-award maximum is specified in the first-level call section. The NOFO gives a total FY 2027 pool and number of awards, so budgeting should be aligned to project needs and justified in context.

Is this only for clinical trials?

Clinical trials are accepted but not required. It is explicitly clinical-trial optional.

Are there early-stage options?

Yes, if aligned to adaptation/implementation and deployment-focused outcomes. The NOFO supports pilot-level and full-scale approaches when they lead to actionable service evidence.

What happens if a submission has errors?

NIH systems and instructions in the NOFO are strict. If a submission is non-compliant, it may be delayed or not accepted. The key recommendation is to test submission and correct before the due time.

Practical fit map by applicant profile

Strong fit

• Teams with existing evidence-based intervention evidence in younger adults and adaptation plans for older adults
• Organizations connected to service systems, clinics, care networks, or senior-care infrastructures
• Groups with data access to health records, community systems, or implementation analytics
• Investigators experienced in mixed-design or hybrid effectiveness-implementation work

Borderline fit

• Teams introducing novel interventions with no routine-care feasibility plan
• Single-site projects that can’t show scaling or continuity strategies
• Research teams with good clinical design but weak deployment logic
• Proposals focused on general mental health without explicit older adult SMI targeting

How to monitor the opportunity going forward

As of this check, the official source link is the direct NIH NOFO hosted via NIH-supported grants.gov content. The key source should be reviewed again before final submission for any revision notices, application guide updates, and policy notices.

Suggested monitoring sources:

• official NOFO page
• NIH Guide for Grants and Contracts
• grants policy updates relevant to registration and submission
• NIMH clinical support pages and support contacts listed in the NOFO

Required official links

• Full announcement: https://files.simpler.grants.gov/opportunities/3702dc53-99c8-4506-ac67-4a017e0bdc73/attachments/044c57b7-0b86-48a9-b432-1f5f6d369a3d/RFA-MH-27-180-Full-Announcement.html
• NIH Grants and related application guidance: https://grants.nih.gov
• eRA Commons / Grants.gov registration and submission portals (linked in the NOFO)